Perioperative complication management protocol for lung cancer ablation

Construction and application of perioperative complication management protocol for lung cancer ablation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN65169553

Enrollment

272

Registered

2025-07-23

Start date

2023-12-01

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scientific management of perioperative complications in patients undergoing lung cancer ablation Cancer

Interventions

The control group received routine management, and the experimental group received management using the constructed perioperative complication management protocol for lung cancer ablation. The method

the importance of intraoperative cooperation and compliance

medical staff were responsible for observing and managing adverse events or complications during surgery, with image acquisition and scanning supervised by other CT room technicians

postoperatively, patients returned to the ward where responsible nurses closely observed vital sign changes and complication occurrence, such as hemoptysis, respiration, heart rate, blood pressure ind

patients received telephone follow-up every 3 months after discharge. The experimental group received management using the constructed perioperative complication management protocol for lung cancer a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients meeting lung tumor diagnostic criteria scheduled for elective lung cancer ablation treatment 2. Clear consciousness, normal thinking, able to communicate verbally and in writing 3. Cooperative with the study and signed informed consent

Exclusion criteria

Exclusion criteria: 1. Severe bleeding tendency, platelets 18s, prothrombin activity 3

Design outcomes

Primary

Measure	Time frame
1. Perioperative complication incidence (perioperative complication incidence = total number of perioperative complications / total number of lung cancer ablation patients) at 3 months after surgery measured using study data collected from case report forms 2. Quality of life measured using Functional Assessment of Cancer Therapy-General (FACT-G) scale before intervention and 3 months after surgery 3. Patient Satisfaction measured using a self-designed satisfaction questionnaire (Satisfaction rate for each group = (very satisfied + satisfied) / total cases in each group × 100%) at 3 months after surgery 4. Preoperative Anxiety Level using a Self-rating Anxiety Scale before surgery	—

Measure

Time frame

1. Perioperative complication incidence (perioperative complication incidence = total number of perioperative complications / total number of lung cancer ablation patients) at 3 months after surgery measured using study data collected from case report forms 2. Quality of life measured using Functional Assessment of Cancer Therapy-General (FACT-G) scale before intervention and 3 months after surgery 3. Patient Satisfaction measured using a self-designed satisfaction questionnaire (Satisfaction rate for each group = (very satisfied + satisfied) / total cases in each group × 100%) at 3 months after surgery 4. Preoperative Anxiety Level using a Self-rating Anxiety Scale before surgery

—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

China

Contacts

Public ContactLihua Huang

huanglh2025lh@163.com+86-02165115006

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026